Segment Information (Tables)

3 Months Ended

Dec. 31, 2018

Segment Reporting [Abstract]

Financial Information for Business Segments

The following is the summary of the financial information for the Company’s operating and reportable segments for the three months ended December 31, 2018 and 2017 and balances as of December 31, 2018 and September 30, 2018(in thousands):

	Brooks
	Semiconductor		Brooks
	Solutions Group		Life Sciences		Total
Three Months Ended December 31, 2018:
Revenue
Products	$	101,801	$	39,931	$	141,732
Services		10,906		26,730		37,636
Segment revenue	$	112,707	$	66,661	$	179,368
Gross profit	$	45,915	$	26,166	$	72,081
Segment operating income		16,141		1,590		17,731
Depreciation expense		916		2,771		3,687
Three Months Ended December 31, 2017:
Revenue
Products	$	83,791	$	21,981	$	105,772
Services		11,366		25,461		36,827
Segment revenue	$	95,157	$	47,442	$	142,599
Gross profit	$	38,494	$	15,765	$	54,259
Segment operating income (loss)		11,718		(1,396)		10,322
Depreciation expense		996		1,549		2,545
Assets:
December 31, 2018	$	288,891	$	915,944	$	1,204,835
September 30, 2018		264,452		410,581		675,033

Reconciliation of Reportable Segment Operating Income (Loss) to Corresponding Consolidated Amounts

	Three Months Ended
	December 31,
	2018		2017
Segment operating income	$	17,731	$	10,322
Amortization of acquired intangible assets		5,768		4,588
Restructuring charges		59		—
Other unallocated corporate expenses		6,571		809
Total operating income	$	5,333	$	4,925

Reconciliation of Reportable Segment Assets to Corresponding Consolidated Amounts

	December 31,		September 30,
	2018		2018
Segment assets	$	1,204,835	$	675,033
Cash, cash equivalents and marketable securities		138,308		251,226
Deferred tax assets		23,287		43,798
Assets held for sale		130,301		125,200
Total assets	$	1,496,731	$	1,095,257